
One in four US adults with diabetes used a GLP-1 drug last year, survey finds, ETHealthworld
[ad_1] Bengaluru: More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly and Ozempic from Novo Nordisk are approved in the […]

































































































